|
注册号: Registration number: |
ChiCTR1900024725 |
|
最近更新日期: Date of Last Refreshed on: |
2019-07-25 12:18:17 |
|
注册时间: Date of Registration: |
2019-07-25 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
京津冀地区生活社区自然人群慢性病队列研究 |
|
Public title: |
Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei |
|
注册题目简写: |
CHCN-BTH |
|
English Acronym: |
CHCN-BTH |
|
研究课题的正式科学名称: |
京津冀地区生活社区自然人群慢性病队列研究 |
|
Scientific title: |
Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei |
|
研究课题代号(代码): Study subject ID: |
国家重点研发计划(2016YFC0900603) |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张玲 |
研究负责人: |
张玲 |
|
Applicant: |
Ling Zhang |
Study leader: |
Ling Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 18600963177 |
研究负责人电话:
Study leader's |
+86 18600963177 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zlilyepi@ccmu.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
zlilyepi@ccmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市丰台区右安门外西头条10号 |
研究负责人通讯地址: |
北京市丰台区右安门外西头条10号 |
|
Applicant address: |
10 Xitoutiao, You'anmenwai, Fengtai District, Beijing, China |
Study leader's address: |
10 Xitoutiao, You'anmenwai, Fengtai District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
首都医科大学 |
||
|
Applicant's institution: |
Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学 |
||
|
Affiliation of the Leader: |
Capital Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2018SY81 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学伦理审查委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2018-09-18 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
北京市丰台区右安门外西头条10号 |
||
|
Contact Address of the ethic committee: |
10 Xitoutiao, You'anmenwai, Fengtai District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
首都医科大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Capital Medical University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市丰台区右安门外西头条10号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
10 Xitoutiao, You'anmenwai, Fengtai District, Beijing, China |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
国家重点研发计划(2016YFC0900603) |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
National Key Research and Development Program of China (grant number 2016YFC0900603) |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
慢性非传染性疾病 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
noninfectious chronic disease |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
卫生服务研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Health services reaserch |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
建立京津冀区域社区自然人群队列3.5万人。动态观测京津冀地区重大慢性疾病的患病率及相关危险因素流行规律和趋势,综合分析环境、生活行为方式、遗传等多种暴露因素对重大慢性疾病发生发展的影响。结合京津冀地区慢病特点,开发个体-社区-健康系统的电子健康管理系统,建立个体化慢病全程管理系统;构建疾病风险预测模型,建立风险评估体系。采用暴露组学、生命组学和毒理基因组学等方法,筛选大气污染相关心肺疾病生物标志物。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
To establish cohort based on 350,000 community population in Beijing-Tianjin-Hebei. Observe the prevalence of major chronic diseases and related risk factors in the Beijing-Tianjin-Hebei region and the regularty of epidemic trends dynamicly and analyse the environmental, lifestyle behavior, genetic and other exposure factors on the occurrence and development of major chronic diseases. To develop an individual-community-health system e-health management system based on the characteristics of chronic diseases in the Beijing-Tianjin-Hebei region. To construct disease risk prediction models and risk assessment system . Using methods such as exposure histology, biopsies, and toxicogenomics to screen biomarkers of air pollution-related cardiopulmonary diseases. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.孕妇;2.身体严重残疾不能接受检查者。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. pregnant women; |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2016-07-01 00:00:00至 To 2020-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2017-07-01 00:00:00 至 To 2019-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用多阶段分层整群抽样方法。第一阶段,采用整群抽样,选取京津冀不同地理区域(西北部、中部、东南部)的5个城市。第二阶段,考虑到居民的依从性、人口的稳定性和当地的医疗条件,由当地疾病预防控制中心选择了各市的3-5个社区。最后阶段,在选定社区,签署知情同意书的,符合纳入标准的候选人纳入研究样本。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The cohort recruited participants using multistage stratified cluster sampling method. In stage I, five cities of Beijing-Tianjin-Hebei region were selected by simple cluster sampling. In stage II, 3-5 communities were selected by local centers for disease control. In stage III, participants were recuit in the study. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
通过京津冀自然人群队列研究信息共享平台提供原始数据: http://59.108.16.234:8082/ |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
IPD will be public accessable via website of BTH cohort study information sharing platform: http://59.108.16.234:8082/ |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
纸质问卷,调查相关文件等原始记录均保存于首都医科大学临床流行病学实验室内,录入资料及原始数据保存于项目组专用云盘。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The original records of the paper questionnaire, the investigation and other related documents were stored in the laboratory of clinical epidemiology, Capital Medical University. Electronic questionnaire data and all the electronic original data are stored in the special network database of specialized online database. Input data and original data stored in the project group special cloud disk |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |